SERPINE2, an inhibitor of plasminogen activators, is highly expressed in the human endometrium during the secretory phase
Open Access
- 23 March 2011
- journal article
- Published by Springer Science and Business Media LLC in Reproductive Biology and Endocrinology
- Vol. 9 (1), 38
- https://doi.org/10.1186/1477-7827-9-38
Abstract
Background: SERPINE2, also known as protease nexin-1, belongs to the serine protease inhibitor (SERPIN) superfamily. It is one of the potent SERPINs that modulates the activity of plasminogen activators (PAs). PAs and their SERPIN inhibitors, such as SERPINB2 and SERPINE1, were expressed in the human endometrium and were implicated in implantation. However, expression data about SERPINE2 in the human endometrium is still unknown. Thus, we conducted an investigation to reveal the spatiotemporal and cellular expression of SERPINE2 in the human uterus during the menstrual cycle. Methods: Seven patients who underwent a hysterectomy and samples of 120 archived patients' endometrial curettage or parts of the uterus that were formalin-fixed and embedded in paraffin. Western blotting was performed to evaluate the specificity and sensitivity of the antibody. Immunohistochemistry was conducted to localize the SERPINE2 expression site. Quantitative analysis was conducted to evaluate expression levels of SERPINE2 in various sub-phases of the menstrual cycle. Results: The SERPINE2 protein was primarily detected in the uterine fluid during the mid- and late-secretory phases of the menstrual cycle. It was predominantly expressed in the luminal and glandular epithelium, less in the myometrium, and only dispersedly in certain stromal cells throughout the menstrual cycle. A quantitative analysis of expression levels of SERPINE2 in the glandular epithelium revealed that it was highly expressed in the endometrium during the secretory phase compared to the proliferative phase. Conclusions: The SERPINE2 protein is highly expressed in the endometrium during the secretory phase, indicating that it may participate in tissue remodeling involved in implantation.Keywords
This publication has 28 references indexed in Scilit:
- Spatiotemporal expression of the serine protease inhibitor, SERPINE2, in the mouse placenta and uterus during the estrous cycle, pregnancy, and lactationReproductive Biology and Endocrinology, 2010
- Review of the role of the plasminogen activator system and vascular endothelial growth factor in subfertilityFertility and Sterility, 2008
- Protease Nexin-1 Interacts With Thrombomodulin and Modulates Its Anticoagulant EffectCirculation Research, 2007
- Expression of Prostasin and Protease Nexin-1 in Rhesus Monkey (Macaca mulatta) Endometrium and Placenta During Early PregnancyJournal of Histochemistry & Cytochemistry, 2006
- Serine protease inhibitor‐E2 (SERPINE2) is differentially expressed in granulosa cells of dominant follicle in cattleMolecular Reproduction and Development, 2002
- Prostasin Is a Glycosylphosphatidylinositol-anchored Active Serine ProteasePublished by Elsevier BV ,2001
- Coordinated and cell-specific induction of both physiological plasminogen activators creates functionally redundant mechanisms for plasmin formation during ovulationEndocrinology, 1996
- Characterization of the receptor for protease nexin-I: Protease complexes on human fibroblastsJournal of Cellular Physiology, 1987
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences, 1979
- Release of plasminogen activator from normal and neoplastic endometriumCellular and Molecular Life Sciences, 1979